Meyka Pro banner
BioSig Technologies, Inc.

BioSig Technologies, Inc. (BSGM) Stock Overview

Explore BioSig Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BSGMNASDAQ
HealthcareMedical - Devices
$6.10
$1.65(37.08%)
U.S. Market opens in 45h 45m

BioSig Technologies, Inc. (BSGM)

Meyka AI Score

Z

Key Financials

Market Cap191.1M
P/E Ratio-4.96
EPS (TTM)$-1.05
ROE15.26%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$3.81

BSGM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BioSig Technologies, Inc. (NASDAQ: BSGM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, BioSig Technologies, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BSGM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $3.81 for the NASDAQ listing.

Key metrics behind BioSig Technologies, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.96 and a market capitalization of 191.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BSGM on the NASDAQ.

Price Performance (NASDAQ: BSGM)

1-Day Change
10.51%
5-Day Change
5.17%
1-Month Change
N/A
3-Month Change
16.63%
6-Month Change
951.34%
Year-to-Date (YTD) Change
335.71%
1-Year Change
1812.23%
3-Year Change
-12.86%
5-Year Change
-88.87%
All-Time (Max) Change
-92.40%

Contact Information

203 409 5444
55 Greens Farms Road, Los Angeles, CT, 06880

Company Facts

50 Employees
IPO DateOct 31, 2014
CountryUS

Frequently Asked Questions